STOCK TITAN

AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

AIM ImmunoTech Inc. (NYSE American: AIM) has announced its participation in the 2024 Healthcare Virtual Summit, presented by Maxim Group The company's CEO, Tom Equels, will engage in a fireside chat on Wednesday, October 16th at 12:30 PM ET.

The summit will feature a series of presentations and interactive discussions with CEOs and key management from various healthcare sectors, including biotechnology, diagnostics, medical devices, and healthcare information technology. Maxim Senior Analysts will host these sessions and plan to conduct several topical industry panels.

To attend the virtual event, interested parties need to sign up for M-Vest membership. The company encourages participants to reserve their seats through the provided link.

AIM ImmunoTech Inc. (NYSE American: AIM) ha annunciato la sua partecipazione al 2024 Healthcare Virtual Summit, presentato da Maxim Group. Il CEO dell'azienda, Tom Equels, parteciperà a una chiacchierata informale mercoledì 16 ottobre alle 12:30 ET.

Il summit presenterà una serie di presentazioni e discussioni interattive con CEO e dirigenti di vari settori sanitari, tra cui biotecnologia, diagnostica, dispositivi medici e tecnologia dell'informazione sanitaria. Gli analisti senior di Maxim modereranno queste sessioni e pianificheranno diversi panel tematici sull'industria.

Per partecipare all'evento virtuale, gli interessati devono registrarsi per diventare membri di M-Vest. L'azienda incoraggia i partecipanti a riservare il proprio posto attraverso il link fornito.

AIM ImmunoTech Inc. (NYSE American: AIM) ha anunciado su participación en el 2024 Healthcare Virtual Summit, presentado por Maxim Group. El CEO de la compañía, Tom Equels, participará en una charla distendida el miércoles 16 de octubre a las 12:30 PM ET.

El summit contará con una serie de presentaciones y discusiones interactivas con CEO y alta dirección de diversos sectores de salud, incluyendo biotecnología, diagnóstico, dispositivos médicos y tecnología de la información sanitaria. Los analistas senior de Maxim serán los anfitriones de estas sesiones y planean realizar varios paneles temáticos de la industria.

Para asistir al evento virtual, las partes interesadas deben registrarse como miembros de M-Vest. La compañía anima a los participantes a reservar sus asientos a través del enlace proporcionado.

AIM ImmunoTech Inc. (NYSE American: AIM)가 2024 Healthcare Virtual Summit에 참가한다고 발표했습니다. 이는 Maxim Group이 주최하며, 회사의 CEO인 Tom Equels10월 16일 수요일 오후 12:30 ET에 담화에 참여할 예정입니다.

이번 서밋은 생명공학, 진단, 의료 기기 및 건강 정보 기술 등 다양한 건강 관리 분야의 CEO 및 주요 경영진과의 발표 및 상호 작용 토론으로 구성됩니다. Maxim의 수석 애널리스트가 이 세션을 주관하며 여러 산업 주제 패널을 진행할 계획입니다.

가상 이벤트에 참석하려는 관심 있는 분들은 M-Vest의 회원 가입을 해야 합니다. 회사는 참가자들이 제공된 링크를 통해 좌석을 예약할 것을 권장합니다.

AIM ImmunoTech Inc. (NYSE American: AIM) a annoncé sa participation au 2024 Healthcare Virtual Summit, présenté par Maxim Group. Le PDG de la société, Tom Equels, participera à une discussion informelle le mercredi 16 octobre à 12 h 30 ET.

Le sommet comportera une série de présentations et de discussions interactives avec des PDG et des dirigeants clés de divers secteurs de la santé, y compris la biotechnologie, le diagnostic, les dispositifs médicaux et la technologie de l'information sanitaire. Les analystes seniors de Maxim animeront ces sessions et prévoient de réaliser plusieurs panels thématiques de l'industrie.

Pour assister à l'événement virtuel, les parties intéressées doivent s'inscrire pour devenir membre de M-Vest. L'entreprise encourage les participants à réserver leurs places via le lien fourni.

AIM ImmunoTech Inc. (NYSE American: AIM) hat seine Teilnahme am 2024 Healthcare Virtual Summit bekannt gegeben, der von Maxim Group präsentiert wird. Der CEO des Unternehmens, Tom Equels, wird am Mittwoch, den 16. Oktober um 12:30 Uhr ET an einem informellen Gespräch teilnehmen.

Der Summit wird eine Reihe von Präsentationen und interaktiven Diskussionen mit CEOs und Führungskräften aus verschiedenen Gesundheitssektoren bieten, einschließlich Biotechnologie, Diagnostik, medizinische Geräte und Gesundheitsinformationstechnologie. Die Senior Analysten von Maxim werden diese Sitzungen moderieren und mehrere thematische Branchenpanels planen.

Um an der virtuellen Veranstaltung teilzunehmen, müssen interessierte Parteien eine Mitgliedschaft bei M-Vest beantragen. Das Unternehmen ermutigt die Teilnehmer, ihre Plätze über den bereitgestellten Link zu reservieren.

Positive
  • None.
Negative
  • None.

Live webcast fireside chat on Wednesday, October 16th at 12:30 PM ET

OCALA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that Tom Equels, Chief Executive Officer of AIM, will participate in a fireside chat at the 2024 Healthcare Virtual Summit, presented by Maxim Group LLC on October 16, 2024 at 12:30 PM ET.

Maxim Senior Analysts will host a wide range of biotechnology, diagnostic, medical device, and healthcare information technology companies in a series of presentations and interactive discussions with CEOs and key management. Maxim also plans to host several topical industry panels that promise to be timely and engaging. To attend, just sign up to become an M-Vest member and stay tuned for more updates.

Click Here to Reserve Your Seat.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational drug called Ampligen® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system.

For more information, please visit aimimmuno.com and connect with the Company on XLinkedIn, and Facebook.


FAQ

When is AIM ImmunoTech participating in the 2024 Healthcare Virtual Summit?

AIM ImmunoTech (NYSE American: AIM) is participating in the 2024 Healthcare Virtual Summit on Wednesday, October 16th, 2024. The company's CEO, Tom Equels, will be part of a fireside chat at 12:30 PM ET.

Who is presenting the 2024 Healthcare Virtual Summit that AIM ImmunoTech is participating in?

The 2024 Healthcare Virtual Summit is being presented by Maxim Group AIM ImmunoTech (NYSE American: AIM) has announced its participation in this event.

How can I attend the 2024 Healthcare Virtual Summit where AIM ImmunoTech is participating?

To attend the 2024 Healthcare Virtual Summit where AIM ImmunoTech (NYSE American: AIM) is participating, you need to sign up to become an M-Vest member. A link is provided in the announcement to reserve your seat for the virtual event.

What types of companies will be featured at the 2024 Healthcare Virtual Summit alongside AIM ImmunoTech?

The 2024 Healthcare Virtual Summit will feature companies from various healthcare sectors, including biotechnology, diagnostics, medical devices, and healthcare information technology. AIM ImmunoTech (NYSE American: AIM) is among the participating companies.

AIM ImmunoTech Inc.

NYSE:AIM

AIM Rankings

AIM Latest News

AIM Stock Data

13.35M
58.01M
8.57%
14.08%
0.77%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
OCALA